Since 2010 over 250,000 research papers have been published on non-coding RNA (ncRNA) [1]. Of relevance to biotechnology, nearly 90,000 of those papers discuss ncRNA and disease, and 70,000 discuss using ncRNA as therapeutic agents (drugs) or being drug targets. The following sections introduce the drivers for ncRNA ...
Wayfinder Biosciences is a biotechnology company developing orally available small molecule drugs that modulate the function of the RNAs encoding key disease targets. The company’s proprietary platform combines unique screening and computational technologies to rapidly discover potent, selective and biologically active RNA-targeting small molecules. Wayfinder’s programs are focused on ...
